Skip to main content
Log in

Luekocyte adherence inhibition in response to human orbital and lacrimal extracts in patients with Graves’ ophthalmopathy

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Leukocyte adherence inhibition (LAI) may be a test for cell-mediated immunity or cy-tophilic antibodies. LAI tests were carried out on patients with Graves’ ophthalmopathy, using normal human lacrimal gland, orbital fat, and eye muscle extracts as antigens. The results were expressed as % LAI. The percentage leukocyte adherence inhibition in tests from patients and normal subjects were not significantly different for any preparation (Mann-Whitney tests). Taking the upper limit of normal as the mean % LAI +2SD for normal subjects, tests were positive, to eye muscle extract, in only one patient whilst borderline inhibition, in response to eye muscle and fat extracts respectively, was demonstrated in two patients. All three had active disease. LAI tests may be positive only during the acute stage of Graves’ ophthalmopathy. The significance of these findings in respect to the pathogenesis of Graves’ ophthalmopathy is discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Doniach D., Florin-Christensen A. Autoimmunity in the pathogenesis of endocrine exophthalmos. Clin. Endocrinol. Metab. 4: 341, 1975.

    Article  CAS  Google Scholar 

  2. Volpé R. The role of autoimmunity in hypoendocrine and hyperen-docrine function: with special emphasis on autoimmune thyroid disease. Ann. Intern. Med. 87: 86, 1977.

    Article  PubMed  Google Scholar 

  3. Wall J.R., Strakosch C.R., Fang S.L., Joyner D., Ingbar S.H., Braverman L.E. Thyroid binding antibodies and other immunological abnormalities in patients with Graves’ ophthalmopathy: effect of treatment with cyclophosphamide. Clin. Endocrinol. (Oxf.) 10: 79, 1979.

    Article  CAS  Google Scholar 

  4. Mahieu P., Winand R. Demonstration of delayed hypersensitivity to retrobulbar and thyroid tissues in human exophthalmos. J. Clin. Endocrinol. Metab. 34: 1090, 1972.

    Article  Google Scholar 

  5. Munro R.E., Lamki L, Row V.V., Volpé R. Cell-mediated immunity in the exophthalmos of Graves’ disease as demonstrated by the migration inhibition fac tor (MIF) test. J. Clin. Endocrinol. Metab. 37: 286, 1973.

    Article  PubMed  CAS  Google Scholar 

  6. Winand R., Mahieu P. Prevention of malignant exophthalmos after treatment of thyrotoxicosis. Lancet 1: 1196, 1973.

    Article  PubMed  CAS  Google Scholar 

  7. Mullin B.R.. Levmson R.E., Friedman A., Henson D.E., Winand R.J., Kohn L.D. Delayed hypersensitivity in Graves’ disease and exophthalmos: identification of thyroglobulin in normal human orbital muscle. Endocrinology 100: 351, 1977.

    Article  PubMed  CAS  Google Scholar 

  8. Wall J.R., Odgers R., Hetzel B.S. Immunological studies of the eye changes of thyrotoxicosis. Aust. N.Z.J. Med. 3: 162, 1973.

    Article  PubMed  CAS  Google Scholar 

  9. Day R. Clinical and pathological manifestations of eye changes, the thyroid: a functional and clinical test. In: Werner S.C., Ingbar S.H. (Eds.), The thyroid. Harper & Row, New York. 1971. p. 539.

    Google Scholar 

  10. Halliday W.J., Miller S. Leukocyte adherence inhibition: a simple test for cell-mediated tumor immunity and serum blocking factors. Int. J. Cancer. 9: 477, 1972.

    Article  PubMed  CAS  Google Scholar 

  11. Halliday W.J., Maluish A.E., Isbister W.H. Detection of anti-tumor cell-mediated immunity and serum blocking factors in cancer patients by the leukocyte adherence inhibition test. Br. J. Cancer 29: 31, 1974.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  12. Grosser N., Marti J.H., Proctor J.W., Thomson D.M.P. Tube leukocyte adherence inhibition assay for the detection of anti-tumor immunity. I. Monocyte is the reactive cell. Int. J. Cancer 18: 39, 1976.

    CAS  Google Scholar 

  13. Marti J.H., Grosser N., Thomson D.M.P. Tube leukocyte adherence inhibition assay for the detection of anti-tumor immunity II. Monocyte reacts with tumor antigen via cytophilic anti-tumor antibody. Int. J. Cancer 18: 48, 1976.

    Article  PubMed  CAS  Google Scholar 

  14. Boyum A. Separation of leukocytes from blood and bone marrow. Scand. J. Clin. Lab. Invest. 21: 9, 1968. (Suppl. 97).

    CAS  Google Scholar 

  15. Holan V., Hasek M., Pubenik J., Chutna J. Antigen-mediated macrophage adherence inhibition. Cell, immunol. 13: 107, 1974.

    Article  CAS  Google Scholar 

  16. Grosser N., Thomson D.M.P. Cell-mediated anti-tumor immunity in breast cancer patients evaluated by antigen induced leukocyte adherence inhibition in test tubes. Cancer Res. 35: 2571, 1975.

    PubMed  CAS  Google Scholar 

  17. Walters B.A., Chick J.E., Halliday W.J. Cell-mediated immunity and serum blocking factors in patients with chronic dermatophytic infections. Int. Arch. Allergy Appl. Immunol. 46: 49, 1974.

    Article  Google Scholar 

  18. Rutherford J.C., Walters B.A.J., Cavaye G., Halliday W.J. A modified leukocyte adherence inhibition test in the laboratory investigation of gastrointestinal cancer. Int. J. Cancer 19: 43, 1977.

    Article  PubMed  CAS  Google Scholar 

  19. Schnieder W.C., Hogeboom G.H. Intracellular distribution of enzymes: V. Further studies on the distribution of cytochrome c in rat liver homogenates. J. Biol. Chem. 183: 123, 1950.

    Google Scholar 

  20. Wall J.R., Walters B.A. Peripheral blood lymphocyte transformation and leukocyte adherence inhibition in response to human testis fractions in patients with lepromatous leprosy. (Submitted).

  21. Teng C.S., Smith B.R., Clayton B., Evered D.C., Clark F., Hall R. Thyroid-stimulating immunoglobulins in ophthalmic Graves’ disease. Clin. Endocrinol. (Oxf.) 6: 207, 1977.

    Article  CAS  Google Scholar 

  22. Solomon D.H., Chopra I.J., Chopra U., Smith F.J. Long-acting thyroid stimulator protector assay as a basis for identification of subgroups of Graves’ ophthalmopathy. Trans. Assoc. Phys. 89: 159, 1976.

    CAS  Google Scholar 

  23. Wall J.R., Trewin A., Fang S.L., Ingbar S.A., Braverman L.E. Studies of immunoreactivity to human lacrimal gland fractions in patients with ophthalmic Graves’ disease. J. Endocrinol. Invest. 1: 253, 1978.

    Article  PubMed  CAS  Google Scholar 

  24. Etienne J., Kohn L.D., Winand R.J. Studies on the mechanisms of experimental exophthalmos. In: Robbins J., Braverman L.E. (Eds.), Thyroid Research. Excerpta Medica International Congress Series 378, Amsterdam, 1976, p. 380.

    Google Scholar 

  25. Fakhri O., Hobbs J., R. Detection of antibodies which can cooperate with lymphocytes. Lancet 2: 403, 1972.

    Article  PubMed  CAS  Google Scholar 

  26. Kohn L.D., Winand R.J. Relationship of thyrotropin to exophthalmos-producing substance. J. Biol. Chem. 246: 6570, 1971.

    PubMed  CAS  Google Scholar 

  27. Konishi J., Herman M.M., Kriss J.P. Binding of thyroglobulin-antithyroglobulin immune complex to extraocular muscle membrane. Endocrinology 95: 434, 1974.

    Article  PubMed  CAS  Google Scholar 

  28. Kriss J.P., Medhi S.Z., Sheng R. Mechanisms of cell-mediated cytotoxicity in Graves’ ophthalmopathy. Proceedings of 54th Meeting of American Thyroid Association, Portland, Oregon, September 13–16, 1978. Endocrinology 103 (Suppl.): T1 1978 (Abstract).

  29. Wall J.R., Joyner D.M., Ryan E.A., Wren S.G.F. Effect of experimental hyper and hypothyroidism on B and T lymphocyte reactivity to bacterial, fungal and tissue antigens. In: Pinchera A., Doniach D., Fenzi G.F., Baschieri L. (Eds.), Symposium on Autoimmune Aspects of Endocrine Disorders. Academic Press, New York, in press.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wall, J.R., Walters, B.A.J. & Grant, C. Luekocyte adherence inhibition in response to human orbital and lacrimal extracts in patients with Graves’ ophthalmopathy. J Endocrinol Invest 2, 375–378 (1979). https://doi.org/10.1007/BF03349336

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03349336

Key-words

Navigation